Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. (Q41835248)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 May 2016
edit
Language Label Description Also known as
English
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.
scientific article published on 26 May 2016

    Statements

    Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. (English)
    1 reference
    Yvette Drew
    1 reference
    Jonathan Ledermann
    1 reference
    Geoff Hall
    1 reference
    Daniel Rea
    1 reference
    Ros Glasspool
    1 reference
    Martin Highley
    1 reference
    Gordon Jayson
    1 reference
    Julieann Sludden
    1 reference
    James Murray
    1 reference
    David Jamieson
    1 reference
    Sarah Halford
    1 reference
    Gary Acton
    1 reference
    Zoe Backholer
    1 reference
    Raffaella Mangano
    1 reference
    Alan Boddy
    1 reference
    Nicola Curtin
    1 reference
    Ruth Plummer
    1 reference
    26 May 2016
    1 reference
    114
    1 reference
    e21
    1 reference
    12
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit